"The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of dalbavancin 500 mg (Xydalba, Durata Therapeutics) for acute bacterial skin and skin structure infections (ABSSSI) in ad"...
There are no known cases of overdosage with Varithena™. In clinical studies, total volumes of up to 60 mL of Varithena™ per treatment session have been administered.
Last reviewed on RxList: 12/4/2015
Additional Varithena Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.